FDA Adverse Event Injury Summary report: N

DIASORIN LIASON XL HSV 1 TYPE SPECIFIC ANTIBODY TEST

MDR report key: 16643549 · Received March 29, 2023

Report

Report Number
MW5116080
Event Type
Injury
Date Received
March 29, 2023
Date of Event
June 15, 2022
Report Date
March 27, 2023
Manufacturer
DIASORIN, INC.
Product Code
MXJ
Adverse Event
Yes
Product Problem
Yes
Report Source
Voluntary report
Reporter Location
OR, US
Reporter Occupation
117
Health Professional
Yes

Narratives

Description of Event or Problem · 0

PATIENT HAD A POSITIVE HSV 1 AND 2 TEST ON THE DIASORIN HSV 1 AND 2 IGG TEST, FOLLOWED UP WITH THE WESTERN BLOT WHICH WAS NEGATIVE FOR HSV 1 AND 2. DATE GIVEN IS THE WESTERN BLOT CONFIRMATORY TEST. REFERENCE REPORT: MW5116081.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
391883 DIASORIN LIASON XL HSV 1 TYPE SPECIFIC ANTIBODY TEST ENZYME LINKED IMMUNOSORBENT ASSAY, HERPES SIMPLEX VIRUS, HSV-1 MXJ DIASORIN, INC.

Patients

Seq Age Sex Outcome Treatment
1 29 YR Male Other